Evolution of Endovascular Therapy in Acute Stroke: Implications of Device Development
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Intravenous thrombolysis is an effective treatment for acute ischaemic stroke. However, vascular recanalization rates remain poor especially in the setting of large artery occlusion. On the other hand, endovascular intra-arterial therapy addresses this issue with superior recanalization rates compared with intravenous thrombolysis. Although previous randomized controlled studies of intra-arterial therapy failed to demonstrate superiority, the failings may be attributed to a combination of inferior intra-arterial devices and suboptimal selection criteria. The recent results of several randomized controlled trials have demonstrated significantly improved outcomes, underpinning the advantage of newer intra-arterial devices and superior recanalization rates, leading to renewed interest in establishing intra-arterial therapy as the gold standard for acute ischaemic stroke. The aim of this review is to outline the history and development of different intra-arterial devices and future directions in research.
Abstract
Intravenous thrombolysis is an effective treatment for acute ischaemic stroke. However, vascular recanalization rates remain poor especially in the setting of large artery occlusion. On the other hand, endovascular intra-arterial therapy addresses this issue with superior recanalization rates compared with intravenous thrombolysis. Although previous randomized controlled studies of intra-arterial therapy failed to demonstrate superiority, the failings may be attributed to a combination of inferior intra-arterial devices and suboptimal selection criteria. The recent results of several randomized controlled trials have demonstrated significantly improved outcomes, underpinning the advantage of newer intra-arterial devices and superior recanalization rates, leading to renewed interest in establishing intra-arterial therapy as the gold standard for acute ischaemic stroke. The aim of this review is to outline the history and development of different intra-arterial devices and future directions in research.
참고문헌 (43)
- Saver JL, "Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke", JAMA, 23, pp.2480~2488 (2013)
- Wardlaw JM, "Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis", Lancet, 379, pp.2364~2372 (2012)
- Bhatia R, "Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke : real-world experience and a call for action", Stroke, 41, pp.2254~2258 (2010)
- Rubiera M, "Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke", Stroke, 36, pp.1452~1456 (2005)
- Sandercock P, "Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke", Trials, 9, pp.37~ (2008)
- Broderick JP, "Endovascular therapy after intravenous t-PA versus t-PA alone for stroke", N Engl J Med, 368, pp.893~903 (2013)
- Kidwell CS, "A trial of imaging selection and endovascular treatment for ischemic stroke", N Engl J Med, 368, pp.914~923 (2013)
- Ciccone A, "Endovascular treatment for acute ischemic stroke", N Engl J Med, 368, pp.904~913 (2013)
- Saver JL, "Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial", Lancet, 380, pp.1241~1249 (2012)
- Nogueira RG, "Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial", Lancet, 380, pp.1231~1240 (2012)
- Rohde S, "Mechanical thrombectomy in acute embolic stroke: preliminary results with the revive device", Stroke, 42, pp.2954~2956 (2011)
- Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med, 372, pp.11~20 (2015)
- Campbell BC, "Endovascular therapy for ischemic stroke with perfusion-imaging selection", N Engl J Med, 372, pp.1009~1018 (2015)
- Goyal M, "Randomized assessment of rapid endovascular treatment of ischemic stroke", N Engl J Med, 372, pp.1019~1030 (2015)
- Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke", N Engl J Med (2015)[DOI]
- Jovin TG, "Thrombectomy within 8 hours after symptom onset in ischemic stroke", N Engl J Med (2015)[DOI]
- Bracard S, "THRACE: Trial and cost effectiveness evaluation of intra-arterial thrombectomy in acute ischemic stroke", european stroke organisation (ESO) conference (2015)
- Mocco J, "THERAPY: The randomized, concurrent controlled trial to assess the penumbra system’s safety and effectiveness in the treatment of acute stroke", european stroke organisation (ESO) conference (2015)
- The IMS Study Investigators, "Combined intravenous and intra-arterial recanalization for acute ischemic stroke : the Interventional Management of Stroke Study", Stroke, 35, pp.904~911 (2004)
- Meyers PM, "Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery", Circulation, 119, pp.2235~2249 (2009)
- Del Zoppo GJ, "PROACT: a phase ii randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism", Stroke, 29, pp.4~11 (1998)
- Furlan A, "Intra-arterial prourokinase for acute ischemic stroke", JAMA, 282, pp.2003~2011 (1999)
- Ogawa A, "Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan", Stroke, 38, pp.2633~2639 (2007)
- Lewandowski CA, "Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke : Emergency Management of Stroke(EMS)Bridging Trial", Stroke, 30, pp.2598~2605 (1999)
- The IMS II Trial Investigators, "The interventional management of stroke (IMS) II study", Stroke, 38, pp.2127~2135 (2007)
- Mazighi M, "Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study)", Lancet Neurol, 8, pp.802~809 (2009)
- Smith WS, "Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial", Stroke, 39, pp.1205~1212 (2008)
- Mourand I, "Mechanical thrombectomy in acute ischemic stroke: catch device", AJNR Am J Neuroradiol, 32, pp.1381~1385 (2011)
- "Covidien Revascularization Device Receives FDA Clearance" (2012)[URL]
- Papanagiotou P, "Treatment of acute cerebral artery occlusion with a fully recoverable intracranial stent", Circulation, 121, pp.2605~2606 (2010)
- Natarajan SK, "Retrievable, detachable stent-platform-based thrombectomy device (SolitaireTM FR) for acute stroke revascularization: first demonstration of feasibility in a canine stroke model", Vasc Dis Manag, 7, pp.120~125 (2010)
- San Román L, "Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke", Stroke, 43, pp.1657~1659 (2012)
- Bose A, "The penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism", AJNR Am J Neuroradiol, 29, pp.1409~1413 (2008)
- Hernandez E, "Benefits of catheter thrombectomy during carotid stenting: a preliminary study", Tex Heart Inst J, 36, pp.404~408 (2009)
- Higashida RT, "Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke", Stroke, 34, pp.e109~e137 (2003)
- Frei D, "The SPEED study: initial clinical evaluation of the Penumbra novel 054 Reperfusion Catheter", J Neurointerv Surg, 5(Suppl 1), pp.i74~i76 (2013)
- Penumbra Pivotal Stroke Trial Investigators, "The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive", Stroke, 40, pp.2761~2768 (2009)
- Tarr R, "The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe", J Neurointerv Surg, 2, pp.341~344 (2010)
- Barber PA, "Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score", Lancet, 355, pp.1670~1674 (2000)
- Saver J., "SolitaireTM FR as Primary Treatment for Acute Ischemic Stroke (SWIFT PRIME)", Clinicaltrials.gov (2013)
- Nogueira RG, "Preliminary data for the DAWN trial (DWI and CTP assessment in the triage of wake-up and late presenting strokes undergoing neurointervention): imaging based endovascular therapy for proximal aneterior circulation occlusions beyond 8 h from last seen well", J Neurointerven Surg, 1, pp.85~ (2009)
- "Trevo and medical management versus medical management alone in wake up and late presenting strokes (DAWN)" (2014)[URL]
- "PISTE (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) trial" (2014)[URL]
